+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Cell Counting Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 5176364
  • Report
  • August 2020
  • Region: Global
  • 110 pages
  • Mordor Intelligence
UP TO OFF
until Dec 31st 2020

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Agilent Technologies
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories
  • Biotek Instruments
  • F. Hoffmann-La Roche
  • Ge Healthcare
  • MORE
The cell counting market is projected to register a CAGR of 6.6% over the forecast period. The major factor attributing to the growth of the market is the rising incidence of target diseases, like HIV, measles, diphtheria, and chronic diseases like cancer and other blood disorders.
  • According to the World Health Organization (WHO), it is estimated that in 2018, nearly 37.9 million individuals had HIV, globally. It has been identified that most of this prevalence is in low and middle-income countries, with an estimated 66% living in sub-Saharan Africa. As per a report published by Meryem Jefferies et al. in the World Journal of Clinical Cases 2018, every year 1.4 million people die from viral hepatitis-related cirrhosis and liver cancer. Thus, rising cases of infectious diseases are ultimately expected to increase the demand in the cell counting market.
Key Market Trends

The Instruments Segment is Expected to Dominate the Market

The dominant share of the segment is attributed to the increasing usage of the cell counters in various applications, like research, diagnostics, and industrial. Cell counting instruments are increasingly being adopted in various areas of research, such as cancer biology, immunology, and neuroscience, which displays exponential growth opportunities for the market. Increasing chronic diseases increase the demand for the instruments.

According to the UNAIDS, 37.9 million people globally were affected with HIV, 1.7 million became newly infected with HIV, and 770 000 people died from AIDS-related illnesses by the end of 2018. The increasing patient pool and increasing research and development propelled the market growth.

North America Dominates the Market and is Expected to do Same in the Forecast Period

North America is expected to dominate the overall cell counting market, throughout the forecast period. The largest share is mainly due to the presence of a larger patient pool and increasing geriatric population. In the North America region, the United States holds the largest market share due to factors, such as the increasing number of chronic diseases, along with a growing number of research and development programs in the country. According to the latest estimates from the Centers for Disease Control and Prevention, 37,832 people received HIV diagnosis in the United States, in 2018. As per the statistics, the large patient pool and high disposable income propelled the market growth in the region.

Competitive Landscape

The cell counting market is moderately competitive. A few of the crucial approaches followed by players are product advancement, invention, acquisitions, and mergers. Some of the companies currently dominating the market are Beckman Coulter Inc., Thermo Fisher Scientific, Becton, Dickinson and Company, Merck, Bio-Rad Laboratories, and GE Healthcare.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Agilent Technologies
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories
  • Biotek Instruments
  • F. Hoffmann-La Roche
  • Ge Healthcare
  • MORE
1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Incidence of Target Diseases and Blood Disorders
4.2.2 Growing Use of High-throughput Flow Cytometry and Automated Hematology Analyzers
4.3 Market Restraints
4.3.1 High Cost of Advanced Cell Counting Systems and Product Recalls of Hematology Analyzers
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Instruments
5.1.1.1 Spectrophotometers
5.1.1.2 Flow Cytometers
5.1.1.3 Hematology Analyzers
5.1.1.4 Cell Counters
5.1.2 Consumables
5.1.2.1 Media, Sera, and Reagents
5.1.2.2 Assay Kits

5.1.2.3 Other Consumables
5.2 Geography
5.2.1 North America
5.2.1.1 United States
5.2.1.2 Canada
5.2.1.3 Mexico
5.2.2 Europe
5.2.2.1 Germany
5.2.2.2 United Kingdom
5.2.2.3 France
5.2.2.4 Italy
5.2.2.5 Spain
5.2.2.6 Rest of Europe
5.2.3 Asia-Pacific
5.2.3.1 China
5.2.3.2 Japan
5.2.3.3 India
5.2.3.4 Australia
5.2.3.5 South Korea
5.2.3.6 Rest of Asia-Pacific
5.2.4 Middle-East and Africa
5.2.4.1 GCC
5.2.4.2 South Africa
5.2.4.3 Rest of Middle-East and Africa
5.2.5 South America
5.2.5.1 Brazil
5.2.5.2 Argentina
5.2.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Beckman Coulter Inc.
6.1.2 Thermo Fisher Scientific
6.1.3 Becton, Dickinson and Company
6.1.4 Merck
6.1.5 Bio-Rad Laboratories
6.1.6 Ge Healthcare
6.1.7 Agilent Technologies
6.1.8 F. Hoffmann-La Roche
6.1.9 Siemens Healthineers
6.1.10 Biotek Instruments

7 MARKET OPPORTUNITIES AND FUTURE TRENDS
Note: Product cover images may vary from those shown

Loading
LOADING...

  • Beckman Coulter Inc.
  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • Merck
  • Bio-Rad Laboratories
  • Ge Healthcare
  • Agilent Technologies
  • F. Hoffmann-La Roche
  • Siemens Healthineers
  • Biotek Instruments
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll